Corbus Pharmaceuticals
CRBP
CRBP
107 hedge funds and large institutions have $51.1M invested in Corbus Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 42 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
50% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 42
50% less capital invested
Capital invested by funds: $103M → $51.1M (-$51.8M)
Holders
107
Holding in Top 10
1
Calls
$1.39M
Puts
$776K
Top Buyers
| 1 | +$5.57M | |
| 2 | +$1.46M | |
| 3 | +$984K | |
| 4 |
JP Morgan Chase
New York
|
+$285K |
| 5 |
Squarepoint
New York
|
+$276K |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$2.66M | |
| 3 | -$1.4M | |
| 4 |
Rafferty Asset Management
New York
|
-$1.12M |
| 5 |
GAI
General American Investors
New York
|
-$1.08M |